MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Insect venom may seem like an unlikely ally in the discovery of new human pain treatments, but the latest findings into the ...

Groundbreaking research has transformed our understanding of acupuncture's role in treating sciatica, a debilitating ...

At the age of 38, Rebekah Bell had quit her job and struggled with feelings of inadequacy as a mother due to years of chronic ...

Jill Becher spent more than three years in agonizing pain. After one surgery failed, a riskier treatment provided relief.

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Scientists investigating new treatments for chronic pain in cancer survivors - Around eight out of 10 children survive their ...

Recent evidence suggests that acupuncture can help relieve the pain caused by sciatica, a common condition in which the ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

New research presented at the American Academy of Ophthalmology’s Cornea Subspecialty Day is part of the part of the 8-year ...

Long-term, low-dose antiviral treatment opens doors for treating shingles in the eye. Will antiviral drug valacyclovir ...